LeMaitre to Participate at Upcoming Investor Conferences in March

Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) said management will participate in five investor conferences in March 2026, including presentations and 1x1 meetings.

Events:

• Leerink Partners Global Healthcare Conference — Mar 10, 2026, W South Beach, Miami, presentation 1:00 PM EDT
• Citizens Life Sciences Conference — Mar 11, 2026, Eden Roc Miami Beach, presentation 1:40 PM EDT
• Barclays Annual Global Healthcare Conference — Mar 12, 2026, available for 1x1 meetings
• KeyBanc Capital Markets Healthcare Forum — Mar 17, 2026, virtual, presentation 3:45 PM EDT
• 38th Annual ROTH Conference — Mar 22-24, 2026, available for 1x1 meetings and possible presentation

News Market Reaction – LMAT

-4.85%

-4.85% Session close to close

In the Feb 27 session, LMAT declined 4.85%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March.

Leerink Partners Global Healthcare Conference
Tuesday, March 10, 2026
W South Beach, Miami
Management will present at 1:00 PM EDT

Citizens Life Sciences Conference
Wednesday, March 11, 2026
Eden Roc Miami Beach, Miami
Management will present at 1:40 PM EDT

Barclays Annual Global Healthcare Conference
Thursday, March 12, 2026
Management will be available for 1x1 meetings

KeyBanc Capital Markets Healthcare Forum
Tuesday, March 17, 2026
Virtual
Management will present at 3:45 PM EDT

38^th Annual ROTH Conference
March 22-24, 2026
Management will be available for 1x1 meetings and may also participate in a presentation or fireside chat.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact:
Greg Manker
Director Business Development & Investor Relations
LeMaitre Vascular, Inc.
Phone: (781) 362-1260
Email: gmanker@lemaitre.com

FAQ

When will LeMaitre Vascular (LMAT) present at the Leerink Partners Global Healthcare Conference?

LeMaitre will present on Tuesday, March 10, 2026 at 1:00 PM EDT. According to the company, management will speak at W South Beach in Miami as part of the conference schedule.

What is LeMaitre Vascular's (LMAT) schedule at the Citizens Life Sciences Conference on March 11, 2026?

Management will present on Wednesday, March 11, 2026 at 1:40 PM EDT. According to the company, the session is scheduled at Eden Roc Miami Beach and is part of their March investor outreach.

Will LeMaitre Vascular (LMAT) be available for 1x1 meetings at the Barclays Annual Global Healthcare Conference?

Yes. LeMaitre will be available for 1x1 meetings on Thursday, March 12, 2026. According to the company, management intends to meet privately with investors during the Barclays conference.

How can investors attend LeMaitre Vascular's (LMAT) presentation at the KeyBanc Healthcare Forum?

LeMaitre will present virtually on Tuesday, March 17, 2026 at 3:45 PM EDT. According to the company, the KeyBanc session is virtual, enabling remote investor access to the presentation.

What is LeMaitre Vascular's (LMAT) participation at the 38th Annual ROTH Conference in March 2026?

LeMaitre will be available for 1x1 meetings March 22-24, 2026 and may participate in a presentation or fireside chat. According to the company, management plans both meetings and possible public sessions.

Do the March 2026 investor conferences signal new financial guidance from LeMaitre Vascular (LMAT)?

No specific financial guidance was announced in connection with the conference appearances. According to the company, the disclosures list presentation times and meeting availability only, without earnings or guidance figures.